These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 35649428)

  • 21. Laboratory identification of lupus anticoagulants using the combination of activated partial thromboplastin time and Russell's viper venom at two phospholipid concentrations.
    Akkawat B; Chantarangkul V; Rojnuckarin P; Juntiang J
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S451-8. PubMed ID: 12930024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of various screening and confirmatory tests for the detection of the lupus anticoagulant.
    Forastiero RR; Falcón CR; Carreras LO
    Haemostasis; 1990; 20(4):208-14. PubMed ID: 2122955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mixing studies for lupus anticoagulant: mostly no, sometimes yes.
    Moore GW
    Clin Chem Lab Med; 2020 Mar; 58(4):492-495. PubMed ID: 31874095
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Screening for lupus anticoagulants in patients treated with vitamin K antagonists.
    Isert M; Miesbach W; Stoever G; Lindhoff-Last E; Linnemann B
    Int J Lab Hematol; 2015 Dec; 37(6):758-65. PubMed ID: 26224222
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dilute Russell viper venom time interpretation and clinical correlation: A two-year retrospective institutional review.
    Jacquot C; Wool GD; Kogan SC
    Int J Lab Hematol; 2019 Feb; 41(1):80-86. PubMed ID: 30194751
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterogeneity of lupus anticoagulant (LA) antibodies: LA activity in dilute Russell's Viper Venom Time and dilute Kaolin Clotting Time detect different populations of antibodies in patients with the "antiphospholipid" syndrome.
    Kandiah DA; Krilis SA
    Thromb Haemost; 1998 Aug; 80(2):250-7. PubMed ID: 9716148
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lupus anticoagulant diagnosis in patients receiving direct oral FXa inhibitors at trough levels: A real-life study.
    Gay J; Duchemin J; Imarazene M; Fontenay M; Jourdi G
    Int J Lab Hematol; 2019 Dec; 41(6):738-744. PubMed ID: 31487115
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Combining Taipan snake venom time/Ecarin time screening with the mixing studies of conventional assays increases detection rates of lupus anticoagulants in orally anticoagulated patients.
    Moore GW
    Thromb J; 2007 Sep; 5():12. PubMed ID: 17822554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Guidance from the Scientific and Standardization Committee for lupus anticoagulant/antiphospholipid antibodies of the International Society on Thrombosis and Haemostasis: Update of the guidelines for lupus anticoagulant detection and interpretation.
    Devreese KMJ; de Groot PG; de Laat B; Erkan D; Favaloro EJ; Mackie I; Martinuzzo M; Ortel TL; Pengo V; Rand JH; Tripodi A; Wahl D; Cohen H
    J Thromb Haemost; 2020 Nov; 18(11):2828-2839. PubMed ID: 33462974
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mixing test specific cut-off is more sensitive at detecting lupus anticoagulants than index of circulating anticoagulant.
    Moore GW; Culhane AP; Daw CR; Noronha CP; Kumano O
    Thromb Res; 2016 Mar; 139():98-101. PubMed ID: 26916303
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lupus anticoagulants and thrombosis: clinical association of different coagulation and immunologic tests.
    Galli M; Dlott J; Norbis F; Ruggeri L; Cler L; Triplett DA; Barbui T
    Thromb Haemost; 2000 Dec; 84(6):1012-6. PubMed ID: 11154107
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Alteration in the laboratory profile of a lupus anticoagulant in a patient with non-Hodgkin's lymphoma.
    Moore GW; Kamat AV; Gurney DA; O'Connor O; Rangarajan S; Carr R; Savidge GF
    Clin Lab Haematol; 2004 Dec; 26(6):429-34. PubMed ID: 15596003
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of direct oral anticoagulants on lupus anticoagulant assays in a real-life setting.
    Antovic A; Norberg EM; Berndtsson M; Rasmuson A; Malmström RE; Skeppholm M; Antovic J
    Thromb Haemost; 2017 Aug; 117(9):1700-1704. PubMed ID: 28640321
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Real-world evidence of lupus anticoagulant testing: simultaneous positivity of diluted Russell's viper venom time and silica clotting time increases thrombotic risk prediction.
    Lee Y; Gu JY; Kim HK
    J Thromb Thrombolysis; 2022 Aug; 54(2):318-322. PubMed ID: 35841477
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of a new silica clotting time for diagnosing lupus anticoagulant in patients who meet the clinical criteria for antiphospholipid syndrome.
    Grypiotis P; Ruffatti A; Pengo V; Tonello M; Biasiolo A; Zamboni D; Cavazzana A; Todesco S
    J Clin Lab Anal; 2006; 20(1):15-8. PubMed ID: 16470527
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The dilution effect of equal volume mixing studies compromises confirmation of inhibition by lupus anticoagulants even when mixture specific reference ranges are applied.
    Moore GW; Savidge GF
    Thromb Res; 2006; 118(4):523-8. PubMed ID: 16263154
    [TBL] [Abstract][Full Text] [Related]  

  • 37. New guidelines for lupus anticoagulant: sensitivity and specificity of cut-off values calculated with plasmas from healthy controls in mixing and confirmatory tests.
    Martinuzzo ME; Cerrato GS; Varela ML; Adamczuk YP; Forastiero RR
    Int J Lab Hematol; 2012 Apr; 34(2):208-13. PubMed ID: 22032515
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Some recent developments with lupus anticoagulants.
    Exner T
    Blood Coagul Fibrinolysis; 1994 Apr; 5(2):281-9. PubMed ID: 8054462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Unveiling the complex effects of direct oral anticoagulants on dilute Russell's viper venom time assays.
    Hillarp A; Strandberg K; Gustafsson KM; Lindahl TL
    J Thromb Haemost; 2020 Aug; 18(8):1866-1873. PubMed ID: 32294291
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Performance of Platelin LS and dilute Russell's viper venom for the screening of lupus anticoagulant in patients with venous thromboembolism.
    Morelli VM; Rodrigues CA; Noguti MA; Matos MF; da Silveira RC; Ribeiro AA; Lourenço DM
    Blood Coagul Fibrinolysis; 2007 Jul; 18(5):401-5. PubMed ID: 17581313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.